Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Anterix (ATEX) EBIT (2016 - 2025)

Historic EBIT for Anterix (ATEX) over the last 13 years, with Q4 2025 value amounting to -$9.1 million.

  • Anterix's EBIT fell 22885.38% to -$9.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $83.5 million, marking a year-over-year increase of 36403.66%. This contributed to the annual value of -$11.7 million for FY2025, which is 1572.81% down from last year.
  • As of Q4 2025, Anterix's EBIT stood at -$9.1 million, which was down 22885.38% from $60.7 million recorded in Q3 2025.
  • In the past 5 years, Anterix's EBIT ranged from a high of $60.7 million in Q3 2025 and a low of -$15.0 million during Q2 2024
  • Moreover, its 5-year median value for EBIT was -$8.7 million (2022), whereas its average is -$613150.0.
  • Examining YoY changes over the last 5 years, Anterix's EBIT showed a top increase of 62569.66% in 2024 and a maximum decrease of 68123.06% in 2024.
  • Anterix's EBIT (Quarter) stood at -$12.4 million in 2021, then surged by 32.09% to -$8.4 million in 2022, then surged by 111.53% to $969000.0 in 2023, then soared by 625.7% to $7.0 million in 2024, then tumbled by 228.85% to -$9.1 million in 2025.
  • Its last three reported values are -$9.1 million in Q4 2025, $60.7 million for Q3 2025, and $22.5 million during Q2 2025.